Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration

Donna Crabtree1, Michaël Boyer-Guittaut, Xiaosen Ouyang

  • 1Department of Pathology, University of Alabama at Birmingham, AL 35294, USA.

Neuroscience Letters
|February 9, 2013
PubMed

Insights

Cathepsin D (CD) deficiency in mice alters dopamine levels without affecting behavior or response to MPTP. This suggests lysosomal function impacts neurochemical balance.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Cathepsin D (CD) is a lysosomal protease crucial for α-synuclein degradation and neuronal survival.
  • CD knockout mice exhibit early mortality due to intestinal necrosis.

Purpose of the Study:

  • To investigate the neurochemical and behavioral impact of heterozygous Cathepsin D deficiency.
  • To assess the role of lysosomal function in maintaining neurochemical homeostasis.

Main Methods:

  • Analysis of young adult male heterozygous CD mice and wildtype littermates.
  • Behavioral testing, Western blotting for protein levels (LC3-II, p62, α-synuclein, LAMP1), and measurement of dopamine and its metabolites.
  • MPTP administration to assess response to neurotoxin-induced dopamine depletion.

Main Results:

  • Heterozygous CD mice showed no behavioral abnormalities.
  • Increased LAMP1 levels in the striatum, with higher dopamine and metabolite levels in striatum and olfactory bulbs.
  • Similar depletion of dopamine and metabolites after MPTP administration in both groups.
  • Unchanged levels of dopamine-synthesizing and metabolizing enzymes.

Conclusions:

  • Partial Cathepsin D deficiency leads to altered dopamine homeostasis without affecting behavior or neurotoxin response.
  • Lysosomal function, specifically Cathepsin D, plays a role in regulating dopamine levels in the brain.
  • These findings contribute to understanding the link between lysosomal dysfunction and neurochemical balance.

Related Concept Videos